ResearcherKeele UniversityNo recent work listed
Adeolu Oluwasanmi
Matched on ORCID iD 0000-0002-1669-6968; OpenAlex author ID A5088629152. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy. Co-author DOI 10.1016/j.ijpharm.2023.123304↗
- Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. Co-author DOI 10.1016/j.jconrel.2017.09.027↗
- Nanotechnologies in Pancreatic Cancer Therapy. First author DOI 10.3390/pharmaceutics9040039↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Clare Hoskins · 3 shared papers, 2017–2023 · strength 0.40
- Paper Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreat… DOI 10.1016/j.ijpharm.2023.123304↗
- Paper Nanotechnologies in Pancreatic Cancer Therapy. DOI 10.3390/pharmaceutics9040039↗
- Paper Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. DOI 10.1016/j.jconrel.2017.09.027↗
- Ayesha Manzur · 2 shared papers, 2017 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.